Skip to main content

Want a detailed portfolio tracker?

Maravai LifeSciences (MRVI) P/E (2021 - 2026)

Maravai LifeSciences (MRVI) P/E from Mar 31, 2021 to Jun 3, 2026. The TTM Maravai LifeSciences (MRVI) P/E is -3.60. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Maravai LifeSciences (MRVI)

YearP/EChange
2026-3.60+48.92%
2025-2.42-60.20%
2024-6.07-122.14%
202327.41+253.15%
20227.76-79.02%
202136.99N/A

Comparison Maravai LifeSciences (MRVI) P/E with competitors

Maravai LifeSciences (MRVI) P/E is -3.60.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.05%
NBYStablecoin Development Corp0.10-102.84%
ENLVEnlivex Therapeutics Ltd0.15-104.18%
FGENFibroGen Inc0.24-106.67%
TRAWTraws Pharma Inc0.47-113.14%
FBIOFortress Biotech Inc0.71-119.63%
CHRSCoherus Biosciences Inc0.98-127.19%
ORMPOramed Pharmaceuticals Inc1.47-140.96%
AGENAgenus Inc2.05-156.95%
VIVSVivoSim Labs Inc2.54-170.50%
INVAInnoviva Inc3.19-188.64%
CRMDCorMedix Inc3.65-201.36%
ABEOAbeona Therapeutics Inc4.20-216.91%
VXRTVaxart Inc4.26-218.48%
CVACCureVac N.V.4.45-223.60%
SRPTSarepta Therapeutics Inc4.62-228.56%
GLPGGalapagos NV4.86-235.08%
RIGLRigel Pharmaceuticals4.92-236.77%
ZVRAZevra Therapeutics Inc4.97-238.29%
ABUSArbutus Biopharma Corp5.69-258.30%
CGENCompugen Ltd7.38-305.29%
AUPHAurinia Pharmaceuticals Inc9.25-357.21%
ACADAcadia Pharmaceuticals Inc9.59-366.57%
OMEROmeros Corporation9.88-374.78%
PLXProtalix BioTherapeutics Inc9.91-375.49%
SPROSpero Therapeutics Inc10.73-398.45%
ADMAAdma Biologics Inc11.33-415.01%
SVASinovac Biotech Ltd11.44-417.94%
TBPHTheravance Biopharma Inc11.78-427.41%
HRMYHarmony Biosciences Holdings Inc12.18-438.64%
TGTXTG Therapeutics Inc13.18-466.42%
INCYIncyte Corp13.38-472.05%
SABSSAB Biotherapeutics Inc14.06-490.83%
XOMAXOMA Corp14.95-515.51%
REGNRegeneron Pharmaceuticals Inc14.98-516.48%
PBYIPuma Biotechnology Inc15.05-518.43%
EXELExelixis Inc15.79-539.13%
NAGENiagen Bioscience Inc16.35-554.70%
CPRXCatalyst Pharmaceuticals Inc17.34-582.22%
MDXGMimedx Group Inc17.38-583.07%
ARGXArgen X SE23.07-741.44%
HALOHalozyme Therapeutics Inc23.20-745.03%
XOMAOXOMA Corp25.34-804.64%
VRTXVertex Pharmaceuticals Inc25.66-813.29%
XOMAPXOMA Corp25.67-813.68%
CTMXCytomX Therapeutics Inc25.70-814.46%
ASNDAscendis Pharma A/S26.35-832.70%
RPRXRoyalty Pharma plc - Class A27.50-864.43%
SLNOSoleno Therapeutics Inc29.02-906.69%
LGNDLigand Pharmaceuticals Inc - Class B30.19-939.25%
BMRNBiomarin Pharmaceutical Inc37.51-1142.78%
APLSApellis Pharmaceuticals Inc39.02-1184.87%
KRYSKrystal Biotech Inc39.70-1203.68%
GMABGenmab40.20-1217.75%
ONCBeiGene Ltd67.03-1963.49%
TECHBio-Techne Corp68.59-2007.09%
VCELVericel Corp80.63-2341.67%
PHARPharming Group N.V.87.74-2539.37%
ALNYAlnylam Pharmaceuticals Inc124.93-3573.43%
TLXTelix Pharmaceuticals Ltd139.89-3989.26%
CORTCorcept Therapeutics Inc158.39-4503.57%